Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWN101 Injection in Overweight or Obese Non‑diabetic Adults
CTR20240802Phase 2Completed
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MWN101 in obesity, Overweight, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Mar 2024; status: completed.
02
Drugs
MWN101
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20240802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240802.